University of North Carolina, Chapel Hill: Hypersensitivity trials

The registry lists 15 Hypersensitivity studies with University of North Carolina, Chapel Hill as lead sponsor. 0 are open to participants now and 9 have results posted.

Early Phase 1 1Phase 1 6Phase 2 9No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• FARE Peanut SLIT and Early Tolerance InductionCompletedNCT02304991Phase 2Results posted
• Mechanisms of Desensitization During Peanut Oral ImmunotherapyCompletedNCT01814241Phase 2Results posted
• Sublingual Immunotherapy for Peanut Allergy and Induction of ToleranceCompletedNCT01373242Phase 1/2Results posted
• Determining the Efficacy and Value of Immunotherapy on the Likelihood of Peanut Tolerance: The DEVIL StudyCompletedNCT00932828Phase 2Results posted
• Peanut Oral Immunotherapy and Anti-Immunoglobulin E (IgE) for Peanut AllergyCompletedNCT00932282Phase 1/2Results posted
• Oral Immunotherapy (OIT) for Peanut AllergyCompletedNCT00815035Phase 2Results posted
• A Study of Sublingual Immunotherapy in Peanut-allergic ChildrenCompletedNCT00597727Phase 2Results posted
• Oral Immunotherapy for Peanut Allergy (PMIT)CompletedNCT00597675Phase 2Results posted
• Treatment of Egg Allergy in Children Through Oral Desensitization (EGG OIT)CompletedNCT00597558Not applicableResults posted
• Oral Peanut Immunotherapy for Peanut Allergic PatientsCompletedNCT01891136Early Phase 1
• Walnut Oral Immunotherapy for Tree Nut AllergyWithdrawnNCT01834352Phase 1/2
• A Study of Inhalation of 20,000 EU CCRE in Normal Volunteers Compared to Allergic Asthmatic IndividualsCompletedNCT00839124Phase 1
• In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic AsthmaticsCompletedNCT00836368Phase 1
• Study of Dust Mite Inhalation in HumansCompletedNCT00448851Phase 1
• Immunotherapy for Peanut AllergyCompletedNCT00429429Not applicable